《慢性乙性肝七炎》课件.ppt

Key Message: 3 month double-blind data has already been published 1 year, 2 year, 3 year, 4 year and 5 year data has been presented Previous publications: - 3 month data: Chinese Medical Journal, May 1999;112(5):387-91 - 2 yr data (minus YMDD): Chin J Hepat, June 1999;7(2)80-83 - 2yr YMDD data included in YMDD management paper: Chinese Hepatology, December 1999; 4(4): 194-196 - Key Points After the initial 12 week placebo controlled double-blind period, all patients received open label lamivudine for up to 5 years. From the start of the 4th year, patients who had seroconverted and were